Auriga Partners is an independent technological venture capital company, based in Paris. It invests shareholders' funds in the fields of information technology and life sciences.

The company invests in innovative projects marked by high potential, either in their creation or at an early development stage, in Europe, North America and Israel. Auriga Partners now manages three funds, a total of more than 198 million euros.

Auriga Partners provides the companies in its portfolio with advice and know-how in structuring managerial teams, internal organization and the creation of strategic partnerships.

Canon Inc., headquartered in Tokyo, Japan is a leader in the fields of professional and consumer imaging equipment and information systems. Originally established in 1937 as Precision Optical Industry, Co., Ltd., a camera manufacturer, Canon has successfully diversified and globalized its operations to become a worldwide industry leader in professional and consumer imaging systems and solutions. Canon has set its sights on the future to provide society with new forms of value, promoting research and development in such areas as medical imaging employing optical-sensor and image- processing technologies.

Crédit Agricole Private Equity is the asset management company of Crédit Agricole S.A., dedicated to private equity investments in unlisted companies.
35 professionals specialising in four activity segments (Expansion Capital & LBO, Venture Capital, Secondary Market, Mezzanine) manage €1,4 billion under French private equity mutual funds (FCPR and FCPI) and private equity companies (SCR).

Crédit Agricole Private Equity advises business managers on their growth plans. Life Sciences investments include Biolipox, Diatos, METabolic Explorer, Fovea Pharmaceuticals...

IXO Private Equity is a private equity firm managing FCPR and FIP and advising IRDI, en evergreen fund.  IXO invests in Venture Capital, LBO and Capital Development. Founded 30 years ago and located in Toulouse, IXO is the most important French regional independent actor in private equity managing €300M. It invests from €500K to €10M by target company in the West and South of France.

Mérieux Développement is the healthcare investment company of Institut Mérieux, a French industrial holding company dedicated to healthcare, which currently employs nearly 10,000 people worldwide. Institut Mérieux has majority ownership of bioMérieux (Euronext Paris, BIM), Silliker, Transgene and ABL Inc. Mérieux Développement intends to invest up to €70 million as minority shareholder from 2010 to 2013 in the field of life science on a global basis, working alongside entrepreneurs and innovative companies whose products and services can bring genuine advances to the health of patients and consumers worldwide.

NBGI Ventures manages the EUR 60m NBG Technology LP, which invests in promising technology-centric companies in Europe, including Greece.

The NBG Technology LP is an independent fund, based in the UK and backed by three prominent financial institutions, including the European Investment Fund (EIF).

Operating from its offices in London and Athens, NBGI Ventures is managed by a dedicated team of professionals with substantial experience in both the technology and financial sectors.
We strongly believe in the value of entrepreneurship and technology and the important role they each play, particularly in today’s competitive, dynamic and uncertain economic environment. We therefore seek exceptional investments that will bring change, innovation and value in their respective industries.